Optic nerve glioma screening

Revision as of 00:33, 6 October 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Optic nerve glioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Optic nerve glioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Optic nerve glioma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Optic nerve glioma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Optic nerve glioma screening

CDC on Optic nerve glioma screening

Optic nerve glioma screening in the news

Blogs on Optic nerve glioma screening

Directions to Hospitals Treating Optic nerve glioma

Risk calculators and risk factors for Optic nerve glioma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

According to the United States Preventive Services Task Force, screening for optic nerve glioma is not recommended.

Screening

According to the United States Preventive Services Task Force, screening for optic nerve glioma is not recommended. However, it is recommended

  • It is recommended that all children with NF-1 have their vision checked every year by an ophthalmologist.
  • Yearly eye exams should begin around 1 year of age and continue until children are at least 10 years of age.
  • In young children with a normal eye exam, a baseline MRI of the brain to look for optic nerve gliomas is not necessary.
  • Treatment of optic nerve glioma should be reserved for children whose tumors are growing actively or causing worsening vision. As most of optic nerve gliomas with NF-1 will not cause vision problems or will not continue to grow, knowing that a child has an optic glioma is not an indication to begin treatment.

References

Template:WH Template:WS